Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral cannabinoid receptor, CB2, regulates bone mass.

Orr Ofek1, Meliha Karsak, Nathalie Leclerc

  • 1Bone Laboratory, Hebrew University of Jerusalem, Jerusalem 91120, Israel.

Proceedings of the National Academy of Sciences of the United States of America
|January 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of surface characteristics on the in vitro stability and cell uptake of nanoliposomes for brain delivery.

Beilstein journal of nanotechnology·2026
Same author

Oral Treatment of Obesity by GLP-1 and Its Analogs.

Pharmaceutics·2025
Same author

Optimizing microRNA delivery via albumin-decorated nanostructured lipid carriers.

International journal of pharmaceutics: X·2025
Same author

Novel development of lipid-based formulations: Improved wettability and homogeneous API solid dispersion visualised via near-infrared hyperspectral imaging.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2025
Same author

Acute high-fat high-sugar diet rapidly increases blood-brain barrier permeability in mice.

The journal of nutrition, health & aging..·2025
Same author

Fatty-acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis.

The FEBS journal·2025
Same journal

Chemotactic self-organization captures the dynamics of mammalian hair follicle patterning.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Tomographic imaging of superconducting order using particle-hole interference.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Improving cell-free metabolism through direct integration of artificial respiratory chains.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

Cannabinoid receptor type 2 (CB2) signaling is crucial for maintaining bone mass. CB2 deficiency accelerates age-related bone loss, suggesting CB2 as a therapeutic target for osteoporosis.

Area of Science:

  • Endocannabinoid System
  • Skeletal Biology
  • Osteoporosis Research

Background:

  • Endogenous cannabinoids interact with cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2).
  • CB1 mediates psychotropic effects, while CB2 is implicated in liver fibrosis and atherosclerosis.
  • The role of CB2 in bone metabolism was previously underexplored.

Purpose of the Study:

  • To investigate the role of cannabinoid receptor type 2 (CB2) in age-related bone loss and bone remodeling.
  • To evaluate the therapeutic potential of CB2 agonists for osteoporosis treatment.

Main Methods:

  • Analysis of CB2-deficient (CB2(-/-)) mice to assess age-related bone loss and remodeling.
  • Histological examination of bone structure, osteoblast, and osteoclast activity.

Related Experiment Videos

  • Administration of a CB2-specific agonist in vivo to evaluate its effects on bone mass and remodeling, including in an ovariectomy-induced bone loss model.

    • Main Results:

    • CB2(-/-) mice exhibited accelerated trabecular bone loss and cortical expansion, mimicking human osteoporosis.
    • CB2 deficiency led to increased osteoblast activity, elevated osteoclast numbers, and reduced osteoblast precursors.
    • A CB2 agonist enhanced osteoblast function, suppressed osteoclastogenesis, and protected against ovariectomy-induced bone loss, increasing cortical thickness.

    Conclusions:

    • The endocannabinoid system, specifically CB2 signaling, is essential for maintaining bone mass.
    • CB2 plays a critical role in regulating both trabecular and cortical bone remodeling.
    • CB2 represents a promising molecular target for the diagnosis and treatment of osteoporosis.